Inventor
REN PINGDA
US138 patents
⚠️ This page may combine multiple inventors who share the name “REN PINGDA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARAXES PHARMA LLC
20 patentsUS9926267B2Mar 27, 2018
Covalent inhibitors of K-Ras G12C
ARAXES PHARMA LLC38 citations98
US9840516B2Dec 12, 2017
Substituted quinazolines as inhibitors of KRAS G12C
ARAXES PHARMA LLC73 citations98
US9227978B2Jan 5, 2016
Covalent inhibitors of Kras G12C
ARAXES PHARMA LLC47 citations98
US10745385B2Aug 18, 2020
Covalent inhibitors of KRAS
ARAXES PHARMA LLC17 citations94
US10736897B2Aug 11, 2020
Compounds and methods of use thereof for treatment of cancer
ARAXES PHARMA LLC28 citations94
US10646488B2May 12, 2020
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
ARAXES PHARMA LLC22 citations94
US10428064B2Oct 1, 2019
Fused-tricyclic inhibitors of KRAS and methods of use thereof
ARAXES PHARMA LLC27 citations94
US10414757B2Sep 17, 2019
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof
ARAXES PHARMA LLC33 citations94
US10377743B2Aug 13, 2019
Inhibitors of RAS and methods of use thereof
ARAXES PHARMA LLC29 citations94
US10370386B2Aug 6, 2019
Substituted quinolines as inhibitors of KRAS G12C
ARAXES PHARMA LLC33 citations94
US10351550B2Jul 16, 2019
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC27 citations94
US10280172B2May 7, 2019
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC34 citations94
US10273207B2Apr 30, 2019
Covalent inhibitors of kras G12C
ARAXES PHARMA LLC24 citations94
US10246424B2Apr 2, 2019
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC36 citations94
US10144724B2Dec 4, 2018
Substituted quinazoline compounds and methods of use thereof
ARAXES PHARMA LLC44 citations94
US9862701B2Jan 9, 2018
Inhibitors of KRAS G12C mutant proteins
ARAXES PHARMA LLC45 citations94
US9745319B2Aug 29, 2017
Irreversible covalent inhibitors of the GTPase K-Ras G12C
ARAXES PHARMA LLC43 citations94
US9988357B2Jun 5, 2018
Methods for preparation of quinazoline derivatives
ARAXES PHARMA LLC38 citations93
US9810690B2Nov 7, 2017
Method for screening inhibitors of Ras
ARAXES PHARMA LLC41 citations93
US10111874B2Oct 30, 2018
Combination therapies for treatment of cancer
ARAXES PHARMA LLC39 citations90
REN PINGDA
12 patentsUS8193182B2Jun 5, 2012
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA93 citations99
US9096611B2Aug 4, 2015
Kinase inhibitors and methods of use
REN PINGDA65 citations98
US8604032B2Dec 10, 2013
Chemical compounds, compositions and methods for kinase modulation
REN PINGDA48 citations98
US8569323B2Oct 29, 2013
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
REN PINGDA61 citations98
US9127000B2Sep 8, 2015
Heterocyclic compounds and uses thereof
REN PINGDA30 citations94
US9085560B2Jul 21, 2015
Heterocyclic compounds and uses thereof
REN PINGDA37 citations94
US8901133B2Dec 2, 2014
Heterocyclic compounds and uses thereof
REN PINGDA44 citations94
US8703777B2Apr 22, 2014
Certain chemical entities, compositions and methods
REN PINGDA36 citations94
US8785454B2Jul 22, 2014
Heterocyclic compounds and uses thereof
REN PINGDA24 citations93
US8703778B2Apr 22, 2014
Heterocyclic kinase inhibitors
REN PINGDA20 citations93
US8785456B2Jul 22, 2014
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA25 citations92
US8809349B2Aug 19, 2014
Processes for preparing isoquinolinones and solid forms of isoquinolinones
REN PINGDA26 citations91
INFINITY PHARMACEUTICALS INC
5 patentsUS9181221B2Nov 10, 2015
Chemical compounds, compositions and methods for kinase modulation
INFINITY PHARMACEUTICALS INC64 citations98
US8940742B2Jan 27, 2015
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC35 citations94
US9388183B2Jul 12, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC19 citations93
US9255108B2Feb 9, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC21 citations93
US9115141B2Aug 25, 2015
Substituted isoquinolinones and methods of treatment thereof
INFINITY PHARMACEUTICALS INC27 citations93
INTELLIKINE LLC
4 patentsUS9359349B2Jun 7, 2016
Substituted quinazolines as kinase inhibitors
INTELLIKINE LLC56 citations98
US9315505B2Apr 19, 2016
Heterocyclic compounds and uses thereof
INTELLIKINE LLC64 citations98
US9522146B2Dec 20, 2016
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
INTELLIKINE LLC10 citations92
US9216982B2Dec 22, 2015
Certain chemical entities, compositions and methods
INTELLIKINE LLC8 citations92
IRM LLC
4 patentsUS7745437B2Jun 29, 2010
Compounds and compositions as protein kinase inhibitors
IRM LLC83 citations97
US7642255B2Jan 5, 2010
Compounds and compositions as protein kinase inhibitors
IRM LLC60 citations97
US7589101B2Sep 15, 2009
Compounds and compositions as protein kinase inhibitors
IRM LLC30 citations92
US7371750B2May 13, 2008
Compounds and compositions as protein kinase inhibitors
IRM LLC21 citations92
CASTRO ALFREDO C
3 patentsUNIV CALIFORNIA
1 patentALBAUGH PAMELA
1 patentShowing the top 50 of 138 patents by PatentIndex Score.